Logo image of BBH

VANECK BIOTECH ETF (BBH) Stock Overview

USA - NASDAQ:BBH - US92189F7261 - ETF

162.187 USD
+1.16 (+0.72%)
Last: 9/26/2025, 8:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BBH. BBH was compared to 81 industry peers in the Automobile Components industry. Both the profitability and the financial health of BBH get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, BBH is valued expensive at the moment. Finally BBH also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BBH was profitable.
BBH had a positive operating cash flow in the past year.
BBH had positive earnings in each of the past 5 years.
BBH had a positive operating cash flow in each of the past 5 years.
BBH Yearly Net Income VS EBIT VS OCF VS FCFBBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

BBH has a Return On Assets (4.39%) which is in line with its industry peers.
BBH has a Return On Equity (8.81%) which is in line with its industry peers.
BBH has a Return On Invested Capital (8.17%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for BBH is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
BBH Yearly ROA, ROE, ROICBBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 5.84%, BBH is in line with its industry, outperforming 48.15% of the companies in the same industry.
BBH's Profit Margin has been stable in the last couple of years.
With a Operating Margin value of 10.65%, BBH perfoms like the industry average, outperforming 49.38% of the companies in the same industry.
BBH's Operating Margin has been stable in the last couple of years.
BBH has a Gross Margin (27.60%) which is in line with its industry peers.
BBH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
BBH Yearly Profit, Operating, Gross MarginsBBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

BBH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BBH has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BBH has been reduced compared to 5 years ago.
Compared to 1 year ago, BBH has a worse debt to assets ratio.
BBH Yearly Shares OutstandingBBH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BBH Yearly Total Debt VS Total AssetsBBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

BBH has an Altman-Z score of 5.17. This indicates that BBH is financially healthy and has little risk of bankruptcy at the moment.
BBH has a better Altman-Z score (5.17) than 87.65% of its industry peers.
BBH has a debt to FCF ratio of 6.05. This is a slightly negative value and a sign of low solvency as BBH would need 6.05 years to pay back of all of its debts.
The Debt to FCF ratio of BBH (6.05) is worse than 65.43% of its industry peers.
BBH has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BBH (0.32) is worse than 62.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 5.17
ROIC/WACC1.05
WACC7.77%
BBH Yearly LT Debt VS Equity VS FCFBBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.80 indicates that BBH should not have too much problems paying its short term obligations.
With a Current ratio value of 1.80, BBH is not doing good in the industry: 74.07% of the companies in the same industry are doing better.
BBH has a Quick Ratio of 1.12. This is a normal value and indicates that BBH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BBH (1.12) is worse than 75.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
BBH Yearly Current Assets VS Current LiabilitesBBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The earnings per share for BBH have decreased strongly by -18.28% in the last year.
BBH shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.64% yearly.
BBH shows a decrease in Revenue. In the last year, the revenue decreased by -3.62%.
BBH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.41% yearly.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

BBH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.63% yearly.
Based on estimates for the next years, BBH will show a small growth in Revenue. The Revenue will grow by 2.56% on average per year.
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BBH Yearly Revenue VS EstimatesBBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
BBH Yearly EPS VS EstimatesBBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

0

4. Valuation

4.1 Price/Earnings Ratio

BBH is valuated quite expensively with a Price/Earnings ratio of 63.35.
Compared to the rest of the industry, the Price/Earnings ratio of BBH indicates a slightly more expensive valuation: BBH is more expensive than 75.31% of the companies listed in the same industry.
BBH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
A Price/Forward Earnings ratio of 37.87 indicates a quite expensive valuation of BBH.
BBH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BBH is more expensive than 79.01% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.05. BBH is valued rather expensively when compared to this.
Industry RankSector Rank
PE 63.35
Fwd PE 37.87
BBH Price Earnings VS Forward Price EarningsBBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BBH's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BBH is more expensive than 77.78% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BBH indicates a slightly more expensive valuation: BBH is more expensive than 74.07% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 79.09
EV/EBITDA 21.03
BBH Per share dataBBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BBH does not grow enough to justify the current Price/Earnings ratio.
BBH's earnings are expected to grow with 15.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)3
PEG (5Y)38.56
EPS Next 2Y18.35%
EPS Next 3Y15.63%

7

5. Dividend

5.1 Amount

BBH has a Yearly Dividend Yield of 4.52%, which is a nice return.
BBH's Dividend Yield is rather good when compared to the industry average which is at 4.02. BBH pays more dividend than 96.30% of the companies in the same industry.
BBH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.52%

5.2 History

The dividend of BBH is nicely growing with an annual growth rate of 7.84%!
BBH has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BBH decreased recently.
Dividend Growth(5Y)7.84%
Div Incr Years1
Div Non Decr Years1
BBH Yearly Dividends per shareBBH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

62.40% of the earnings are spent on dividend by BBH. This is not a sustainable payout ratio.
BBH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
BBH Yearly Income VS Free CF VS DividendBBH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
BBH Dividend Payout.BBH Dividend Payout, showing the Payout Ratio.BBH Dividend Payout.PayoutRetained Earnings

VANECK BIOTECH ETF

NASDAQ:BBH (9/26/2025, 8:00:00 PM)

162.187

+1.16 (+0.72%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners46.28%
Inst Owner Change-21.6%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap114.46B
Analysts80.87
Price Target203.77 (25.64%)
Short Float %0%
Short Ratio1.11
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Yearly Dividend1.58
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.46%
PT rev (3m)21.91%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.32%
EPS NY rev (3m)-10.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE 63.35
Fwd PE 37.87
P/S 3.67
P/FCF 79.09
P/OCF 28.99
P/B 5.53
P/tB 7.52
EV/EBITDA 21.03
EPS(TTM)2.56
EY1.58%
EPS(NY)4.28
Fwd EY2.64%
FCF(TTM)2.05
FCFY1.26%
OCF(TTM)5.59
OCFY3.45%
SpS44.22
BVpS29.31
TBVpS21.58
PEG (NY)3
PEG (5Y)38.56
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 5.17
F-Score5
WACC7.77%
ROIC/WACC1.05
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year59.12%
EBIT Next 3Y22.78%
EBIT Next 5Y17.51%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%